Transcapital advises Nexira group on the acquisition of Tournay Biotechnologies.
Nexira group, the world leader of gum arabic, with a consolidated turnover of €93m in the natural ingredients market, wished to expand its product range and to strengthen its position on the healthcare segment, targeting a 35%-share for these products in the company’s total activity.
To this end, the group entrusted Transcapital with the mission to search potential targets among plant extracts manufacturers in the whole Europe and to advise the group on the acquisition of one or several companies.
The acquisition of Tournay Biotechnologies, recognized specialist in the production of natural plant extracts (cranberry, green coffee, green tea…) for nutraceutical and dietary supplement markets, was exactly in line with this strategy. A family-owned company created in 1992, Tournay Biotechnologies operates a modern industrial plant located near Bordeaux.